Simoa technology is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers.
Automated microscopy and Spatial Proteomics
Automated microscopy and image analysis
Discover
Back to filter
Show all topics (10)
Related topics
Study finds that automated liquid-handling operations are more robust, resilient, and efficient!
Jul 18, 2024
Liquid handling devices (LHD) improve lab efficiency and accuracy. They automate liquid transfers, increase experiment...
Scaling Whole-Genome Sequencing to >50,000 single cells using cellenONE
Jul 16, 2024
cellenONE technology enabled the creation of tens of thousands of high-quality single-cell genomes, paving the way for...
Theranostics: From Mice to Men and Back
Jun 25, 2024
Recorded webinar
Presenters: Prof. Dr. Ken Herrmann and Prof. Dr. Katharina Lückerath – Moderator: Hannah Notebaert
Orion 2024 AACR poster: 17-plex single-step stain and imaging of cell Lung Carcinoma
Jun 21, 2024
RareCyte Orion is a benchtop, high resolution, whole slide multimodal imaging instrument. A combination of quantitative...
Automated Purification of Viral DNA and RNA from Biological Samples usingZymo Research Quick-DNA/RNA
Jun 14, 2024
The Quick DNA/RNA Viral MagBead Kit from Zymo has been automated with the Cybio FeliX pipetting robot from Analytik...
DNA Amplicon Library Preparation for Illumina® Sequencing
Jun 12, 2024
The precision of temperature control, efficient heating and cooling rates, and excellent temperature homogeneity across...
X-RAD 320 for irradiation therapy during quantifying study for in vivo collagen reorganization
Jun 5, 2024
Quantifying in vivo collagen reorganization during immunotherapy in murine melanoma with second harmonic generation...
Exosome-Mediated Delivery of Small Molecules, RNA & DNA for Development of Novel Cancer Therapeutics
Jun 3, 2024
Disha Moholkar of University of Louisville's Gupta Lab
Tuesday, June 11, 2024, 6:30 PM...
Emulate in vivo conditions – introduce shear flow to your experiments with BioFlux system
May 27, 2024
Most research is still conducted in vitro without the presence of flow. We use the BioFlux System to give you the...
High-frequency Ultrasound System For Preclinical Imaging
May 13, 2024
The Prospect T1 is an innovative high-frequency ultrasound system designed specifically for in vivo preclinical imaging...
Study finds\; Plasma p-tau217, p-tau181, and NfL as early indicators of dementia risk of AD
Apr 24, 2024
Recent studies have shown that certain proteins in the blood, like p-tau217 and p-tau181, can indicate Alzheimer´s disease (AD). These proteins are linked to declining cognitive function and the progression to dementia or AD. Among these, p-tau217 seems to be particularly good at predicting the shift from mild cognitive impairment (MCI) to AD dementia. Another marker, blood neurofilament light chain (NfL), is also helpful in predicting cognitive decline and disease progression. Interestingly, these markers seem to be more closely linked to clinical outcomes than amyloid markers. However, most research has focused on hospital patients, so we need studies with community-based participants to confirm these findings in the real world. Additionally, the lack of commercially available tests for plasma p-tau217 has made it difficult to study diverse populations.
Related technologies: Digital biomarker detection
Get more info
Brand profile